Sight Sciences (SGHT) Cash & Current Investments (2020 - 2026)
Sight Sciences (SGHT) posted quarterly Cash & Current Investments of $85.0 million for Q1 2026, down 21.89% year-over-year from $108.8 million in Q1 2025, and down 7.61% quarter-over-quarter from $92.0 million in Q4 2025.
Sight Sciences (SGHT) Cash & Current Investments (2020 - 2026) Analysis & Trends
Sight Sciences' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $85.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 21.89% year-over-year to $85.0 million; the TTM figure through Mar 2026 stood at $85.0 million (down 21.89% YoY), while the FY2025 annual figure was $92.0 million, down 23.59% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $85.0 million, down from $92.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $238.6 million in Q1 2022, with the low at $85.0 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $127.3 million (2024), against an average of $141.9 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 518.74% in 2022, then slipped 29.86% in 2023.
- Sight Sciences' Cash & Current Investments stood at $185.0 million in 2022, then decreased by 25.34% to $138.1 million in 2023, then decreased by 12.87% to $120.4 million in 2024, then declined by 23.59% to $92.0 million in 2025, then decreased by 7.61% to $85.0 million in 2026.
- Business Quant data shows SGHT's Cash & Current Investments at $85.0 million in Q1 2026, $92.0 million in Q4 2025, and $92.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Sight Sciences | 446.40 Mn | 366.65 Mn | 21.37 Mn | 79.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.75 Mn |
| Mar 31, 2026 | 84.96 Mn |
| Dec 31, 2025 | 91.97 Mn |
| Sep 30, 2025 | 92.37 Mn |
| Jun 30, 2025 | 101.50 Mn |
| Mar 31, 2025 | 108.77 Mn |
| Dec 31, 2024 | 120.36 Mn |
| Sep 30, 2024 | 118.56 Mn |
| Jun 30, 2024 | 118.18 Mn |
| Mar 31, 2024 | 127.28 Mn |
| Dec 31, 2023 | 138.13 Mn |
| Sep 30, 2023 | 144.50 Mn |
| Jun 30, 2023 | 154.52 Mn |
| Mar 31, 2023 | 167.34 Mn |
| Dec 31, 2022 | 185.00 Mn |
| Sep 30, 2022 | 199.82 Mn |
| Jun 30, 2022 | 220.10 Mn |
| Mar 31, 2022 | 238.59 Mn |
| Dec 31, 2021 | 260.69 Mn |
| Sep 30, 2021 | 271.48 Mn |